Medicare Enrolled

Dr. Jasmina Rice, M.D.

Pediatrics · Newnan, GA
Low-engagement
189 JEFFERSON PKWY, Newnan, GA 30263
7703042220
In practice since 2005 (20 years)
NPI: 1679557060 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rice from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rice? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rice

Dr. Jasmina Rice is a pediatrics specialist in Newnan, GA, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Rice received a total of $2,055 from 28 pharmaceutical and/or device companies across 106 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatrics. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rice is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $2,055 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,055
Total received (2018-2024)
Avg $294/year across 7 years
Top 8% in GA for pediatrics
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
106
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,055 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$568
2023
$199
2022
$178
2021
$270
2020
$355
2019
$205
2018
$279

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Supernus Pharmaceuticals, Inc.
$163
IRONSHORE PHARMACEUTICALS INC.
$83
Corium, LLC
$74
Verrica Pharmaceuticals Inc.
$44
Phadia US Inc.
$41
Neos Therapeutics, LP
$36
SANOFI-AVENTIS U.S. LLC
$32
Cranial Technologies, Inc
$21
SOBI, INC
$19
kaleo, Inc.
$19
Kyowa Kirin, Inc.
$19
Kowa Pharmaceuticals America, Inc.
$18
Top 3 companies account for 56.4% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$396
Neos Therapeutics, LP
$276
Takeda Pharmaceuticals U.S.A., Inc.
$133
Cranial Technologies, Inc
$131
Tris Pharma Inc
$110
Corium, LLC
$107
kaleo, Inc.
$93
IRONSHORE PHARMACEUTICALS INC.
$83
Shire North American Group Inc
$79
Ironshore Pharmaceuticals Inc.
$79
PFIZER INC.
$79
SANOFI PASTEUR INC.
$65
Phadia US Inc.
$63
Verrica Pharmaceuticals Inc.
$44
Sobi, Inc
$44
Mission Pharmacal Company
$36
Kaleo, Inc.
$34
SOBI, INC
$34
SANOFI-AVENTIS U.S. LLC
$32
Novartis Pharmaceuticals Corporation
$19
Kyowa Kirin, Inc.
$19
Kowa Pharmaceuticals America, Inc.
$18
Circassia Pharmaceuticals Inc
$17
ARBOR PHARMACEUTICALS, INC.
$15
Genentech USA, Inc.
$14
GlaxoSmithKline, LLC.
$13
Adlon Therapeutics L.P.
$13
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 39.2% of all-time payments
Associated products mentioned in payments ›
ADHANSIA XR · AUVI-Q · Adzenys XR-ODT · Auvi-Q · Azstarys · BEXSERO · Cotempla XR-ODT · Crysvita · Doc Band · Dyanavel XR · EUCRISA · FLUZONE QUADRIVALENT · ImmunoCAP · JORNAY PM · MENACTRA · Otovel · PAZEO · PREVNAR - 13 · PREVNAR 13 · Prednisolone 25 · QELBREE · QUADRACEL · Qelbree · Quillichew ER · ROTATEQ · SYNAGIS · Synagis · TROKENDI XR · TUDORZA PRESSAIR · TZIELD · VAXELIS · VYVANSE · Xofluza · YCANTH · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for pediatrics in GA.

Looking for a pediatrics specialist in Newnan?
Compare pediatricians in the Newnan area by procedure volume, costs, and industry payment transparency.
Browse pediatricians nearby

Geographic Context

Pediatricians within 10 mi
50
Per 100K population
33.3
County median income
$94,142
Nearest hospital
PIEDMONT NEWNAN HOSPITAL, INC
8.7 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rice is a pediatrics specialist, with low-engagement industry engagement in the top 8% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Rice receive payments from pharmaceutical companies?
Yes. Dr. Rice received a total of $2,055 from 28 companies across 106 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Rice) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Pediatricians in Newnan
Browse pediatricians in Newnan ranked by procedure volume and transparency data.
Highest volume
Top Pediatricians in GA
Pediatricians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatricians in GA
Which GA pediatricians receive the most from drug and device companies.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
Neos Therapeutics, LP Payments to Doctors
See all physicians who received payments from Neos Therapeutics, LP.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →